Arcturus Therapeutics Holdings (ARCT) Assets Average (2019 - 2026)

Arcturus Therapeutics Holdings' Assets Average history runs 8 years deep, the most recent figure standing at $258.3 million for Q1 2026.

• Quarterly Assets Average fell 23.57% year-over-year to $258.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $258.3 million (down 23.57% YoY) and the FY2025 annual result came in at $307.6 million, down 20.46% from the prior year.
• Assets Average was $258.3 million for Q1 2026 at Arcturus Therapeutics Holdings, down from $276.7 million in the prior quarter.
• Across five years, Assets Average topped out at $460.6 million in Q1 2023 and bottomed at $258.3 million in Q1 2026.
• A 5-year average of $367.5 million and a median of $367.4 million in 2022 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2022 — Assets Average retreated 28.61% — and 2023, when it surged 40.86%.
• Arcturus Therapeutics Holdings' Assets Average stood at $372.0 million in 2022, then climbed by 19.23% to $443.5 million in 2023, then slipped by 19.43% to $357.4 million in 2024, then fell by 22.56% to $276.7 million in 2025, then decreased by 6.67% to $258.3 million in 2026.
• Business Quant data shows ARCT's Assets Average at $258.3 million in Q1 2026, $276.7 million in Q4 2025, and $295.8 million in Q3 2025.